These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9173726)

  • 1. The Third International Feline Retrovirus Research Symposium.
    Burkhard MJ; Hoover EA
    Vaccine; 1997 Feb; 15(2):107-10. PubMed ID: 9173726
    [No Abstract]   [Full Text] [Related]  

  • 2. Vaccination of cats with recombinant envelope glycoprotein of feline immunodeficiency virus: decreased viral load after challenge infection.
    Lutz H; Hofmann-Lehmann R; Leutenegger C; Allenspach K; Cuisinier AM; Cronier J; Duquesne V; Aubert A
    AIDS Res Hum Retroviruses; 1996 Mar; 12(5):431-3. PubMed ID: 8882327
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of live feline immunodeficiency virus vaccines with modified antigenic properties.
    Broche-Pierre S; Richardson J; Moraillon A; Sonigo P
    J Gen Virol; 2005 Sep; 86(Pt 9):2495-2506. PubMed ID: 16099908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lessons from the cat: development of vaccines against lentiviruses.
    Dunham SP
    Vet Immunol Immunopathol; 2006 Jul; 112(1-2):67-77. PubMed ID: 16678276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feline immunodeficiency virus vaccine: implications for diagnostic testing and disease management.
    Richards JR
    Biologicals; 2005 Dec; 33(4):215-7. PubMed ID: 16257536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accelerated viremia in cats vaccinated with recombinant vaccinia virus expressing envelope glycoprotein of feline immunodeficiency virus.
    Osterhaus AD; Tijhaar E; Huisman RC; Huisman W; Darby IH; Francis MJ; Rimmelzwaan GF; Siebelink KH
    AIDS Res Hum Retroviruses; 1996 Mar; 12(5):437-41. PubMed ID: 8882329
    [No Abstract]   [Full Text] [Related]  

  • 7. Protective immunity against feline immunodeficiency virus induced by inoculation with vif-deleted proviral DNA.
    Lockridge KM; Chien M; Dean GA; Stefano Cole K; Montelaro RC; Luciw PA; Sparger EE
    Virology; 2000 Jul; 273(1):67-79. PubMed ID: 10891409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel approaches to vaccination against the feline immunodeficiency virus.
    Pistello M; Conti F; Vannucci L; Freer G
    Vet Immunol Immunopathol; 2010 Mar; 134(1-2):48-53. PubMed ID: 19896725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying FIV vaccinates.
    Murray DM
    J Am Vet Med Assoc; 2003 Mar; 222(6):710. PubMed ID: 12675285
    [No Abstract]   [Full Text] [Related]  

  • 10. Adoptive immunotherapy of feline immunodeficiency virus with autologous ex vivo-stimulated lymphoid cells modulates virus and T-cell subsets in blood.
    Flynn JN; Pistello M; Isola P; Zaccaro L; Del Santo B; Ricci E; Matteucci D; Bendinelli M
    Clin Diagn Lab Immunol; 2005 Jun; 12(6):736-45. PubMed ID: 15939748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination against feline retroviruses.
    Jarrett O
    Dev Biol Stand; 1990; 72():185-8. PubMed ID: 2178114
    [No Abstract]   [Full Text] [Related]  

  • 12. Thoughts on retroviruses.
    Romatowski J
    J Am Vet Med Assoc; 1995 Jun; 206(11):1672. PubMed ID: 7782231
    [No Abstract]   [Full Text] [Related]  

  • 13. Panel report on the colloquium on feline leukemia virus/feline immunodeficiency virus: tests and vaccination.
    J Am Vet Med Assoc; 1991 Nov; 199(10):1273-7. PubMed ID: 1666068
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevalence of feline immunodeficiency virus and feline leukemia virus infections in random-source cats.
    Glennon PJ; Cockburn T; Stark DM
    Lab Anim Sci; 1991 Dec; 41(6):545-7. PubMed ID: 1667194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feline immunodeficiency virus subunit vaccines that induce virus neutralising antibodies but no protection against challenge infection.
    Huisman W; Karlas JA; Siebelink KH; Huisman RC; de Ronde A; Francis MJ; Rimmelzwaan GF; Osterhaus AD
    Vaccine; 1998; 16(2-3):181-7. PubMed ID: 9607028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guidelines on preventing and managing FIV.
    Vet Rec; 2008 Apr; 162(17):531. PubMed ID: 18557221
    [No Abstract]   [Full Text] [Related]  

  • 17. FIV in cats--a useful model of HIV in people?
    Bienzle D
    Vet Immunol Immunopathol; 2014 Jun; 159(3-4):171-9. PubMed ID: 24636302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feline immunodeficiency virus subtype B in domestic cats in Minas Gerais, Brazil.
    Caxito FA; Coelho FM; Oliveira ME; Resende M
    Vet Res Commun; 2006 Nov; 30(8):953-6. PubMed ID: 17139547
    [No Abstract]   [Full Text] [Related]  

  • 19. Serological differentiation of FIV-infected cats from dual-subtype feline immunodeficiency virus vaccine (Fel-O-Vax FIV) inoculated cats.
    Kusuhara H; Hohdatsu T; Seta T; Nemoto K; Motokawa K; Gemma T; Watanabe R; Huang C; Arai S; Koyama H
    Vet Microbiol; 2007 Mar; 120(3-4):217-25. PubMed ID: 17141431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relevance of feline retroviruses to the development of vaccines against HIV.
    Jarrett O
    AIDS Res Hum Retroviruses; 1996 Mar; 12(5):385-7. PubMed ID: 8882315
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.